Department of Medical Microbiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Kumasi Centre for Collaborative Research in Tropical Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Ann N Y Acad Sci. 2020 Apr;1465(1):29-58. doi: 10.1111/nyas.14254. Epub 2019 Oct 24.
A systematic review of antibiotic-resistant Gram-positive bacteria in Africa from a One Health perspective is lacking. Here, we report result from a search for English-language articles on the resistance mechanisms and clonality of Gram-positive bacteria in Africa between 2007 and 2019 reported in PubMed, Web of Science, ScienceDirect, and African Journals OnLine; 172 studies from 22 different African countries were identified. Resistance genes, such as mecA, erm(B), erm(C), tet(M), tet(K), tet(L), vanB, vanA, vanC, and tet(O), were found to be common. Staphylococcus spp., Enterococcus spp., and Streptococcus spp. were the main species reported by the studies, with clones such as Staphylococcus aureus ST5 (n = 218 isolates), ST8 (n = 127 isolates), ST80 (n = 133 isolates), and ST88 (n = 117 isolates), and mobile genetic elements such as IS16 (n = 28 isolates), IS256 (n = 96), Tn916 (n = 107 isolates), and SCCmec (n = 4437 isolates) identified. SCCmec IV (n = 747 isolates) was predominant, followed by SCCmec III (n = 305 isolates), SCCmec II (n = 163 isolates), SCCmec V (n = 135 isolates), and SCCmec I (n = 79 isolates). Resistance to penicillin (n = 5926 isolates), tetracycline (n = 5300 isolates), erythromycin (n = 5151 isolates), rifampicin (n = 3823 isolates), gentamycin (n = 3494 isolates), sulfamethoxazole/trimethoprim (n = 3089 isolates), and ciprofloxacin (n = 2746 isolates) was common in most reports from 22 countries. Clonal dissemination of resistance across countries and between humans, animals, and the environment was observed. Resistance rates ranged from 1.4% to 100% for 15 of the studies; 10 were One Health-related studies. Strict infection control measures, antimicrobial stewardship, and periodic One Health epidemiological surveillance studies are needed to monitor and contain the threat of increasing antibiotic resistance in Africa.
从“同一健康”角度对非洲的抗生素耐药革兰阳性菌进行系统评价尚属空白。在此,我们报告了在 PubMed、Web of Science、ScienceDirect 和 African Journals OnLine 上检索到的 2007 年至 2019 年期间在非洲报道的关于革兰阳性菌耐药机制和克隆性的英文文章的结果,共确定了来自 22 个不同非洲国家的 172 项研究。研究中发现了常见的耐药基因,如 mecA、erm(B)、erm(C)、tet(M)、tet(K)、tet(L)、vanB、vanA、vanC 和 tet(O)。报道的主要菌种有葡萄球菌属、肠球菌属和链球菌属,克隆株如金黄色葡萄球菌 ST5(218 株)、ST8(127 株)、ST80(133 株)和 ST88(117 株)以及移动遗传元件如 IS16(28 株)、IS256(96 株)、Tn916(107 株)和 SCCmec(4437 株)。SCCmec IV(747 株)最为常见,其次是 SCCmec III(305 株)、SCCmec II(163 株)、SCCmec V(135 株)和 SCCmec I(79 株)。对青霉素(5926 株)、四环素(5300 株)、红霉素(5151 株)、利福平(3823 株)、庆大霉素(3494 株)、磺胺甲噁唑/甲氧苄啶(3089 株)和环丙沙星(2746 株)的耐药率在大多数来自 22 个国家的报告中均较高。观察到了耐药性在国家之间以及在人类、动物和环境之间的克隆传播。15 项研究的耐药率范围为 1.4%至 100%;其中 10 项为同一健康相关研究。需要严格的感染控制措施、抗菌药物管理以及定期的同一健康流行病学监测研究,以监测和遏制非洲日益严重的抗生素耐药性威胁。